NCT01431976 Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents Status COMPLETED Phase PHASE3
NCT01431963 Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy Status COMPLETED Phase PHASE3
NCT01431950 Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents Status COMPLETED Phase PHASE3
NCT01431937 Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01431924 Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients Status COMPLETED Phase N/A
NCT01431911 Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation Status COMPLETED Phase N/A
NCT01430572 Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients Status COMPLETED Phase PHASE1
NCT01429376 Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD Status COMPLETED Phase NA
NCT01428544 Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg) Status COMPLETED Phase N/A
NCT01428531 Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment Status COMPLETED Phase N/A
NCT01428505 [18F]PBR111 and Microglial Activation in Multiple Sclerosis Status TERMINATED Phase PHASE2
NCT01428479 Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males Status COMPLETED Phase PHASE1
NCT01428453 A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01428427 Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01426880 Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01425749 Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI Status COMPLETED Phase EARLY_PHASE1